Compounds > valsartan
Page last updated: 2024-08-24

valsartan and Macular Edema

valsartan has been researched along with Macular Edema in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's4 (100.00)2.80

Authors

AuthorsStudies
Blodi, BA; Ip, MS; Oden, NL; Scott, IU; VanVeldhuisen, PC3
Au, A; Blodi, BA; Ip, M; Oden, NL; Sarraf, D; Scott, IU; Van Veldhuisen, PC1

Trials

4 trial(s) available for valsartan and Macular Edema

ArticleYear
SCORE2 Report 17: Macular thickness fluctuations in anti-VEGF-treated patients with central or hemiretinal vein occlusion.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2022, Volume: 260, Issue:5

    Topics: Angiogenesis Inhibitors; Bevacizumab; Humans; Intravitreal Injections; Macular Edema; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Valsartan; Vascular Endothelial Growth Factors

2022
Baseline Characteristics and Outcomes After Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema in Participants With Hemiretinal Vein Occlusion Compared With Participants With Central Retinal Vein Occlusion: Study of Comparative Treatments f
    JAMA ophthalmology, 2022, 05-01, Volume: 140, Issue:5

    Topics: Aged; Angiogenesis Inhibitors; Bevacizumab; Female; Humans; Intravitreal Injections; Macular Edema; Male; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Valsartan

2022
SCORE2 Report 24: Nonlinear Relationship of Retinal Thickness and Visual Acuity in Central Retinal and Hemiretinal Vein Occlusion.
    Ophthalmology, 2023, Volume: 130, Issue:10

    Topics: Angiogenesis Inhibitors; Bevacizumab; Humans; Intravitreal Injections; Macular Edema; Retina; Retinal Vein Occlusion; Tomography, Optical Coherence; Valsartan; Visual Acuity

2023
OCT Grading System of Macular Infarction Predicts Vision in Participants With Central Retinal or Hemiretinal Vein Occlusion: A Secondary Analysis of SCORE2.
    American journal of ophthalmology, 2023, Volume: 256

    Topics: Angiogenesis Inhibitors; Bevacizumab; Cohort Studies; Humans; Intravitreal Injections; Macular Edema; Retinal Vein Occlusion; Tomography, Optical Coherence; Treatment Outcome; Valsartan

2023